These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 29305843)
1. Circulating microparticles levels are increased in patients with diabetic kidney disease: A case-control research. Rodrigues KF; Pietrani NT; Fernandes AP; Bosco AA; de Sousa MCR; de Fátima Oliveira Silva I; Silveira JN; Campos FMF; Gomes KB Clin Chim Acta; 2018 Apr; 479():48-55. PubMed ID: 29305843 [TBL] [Abstract][Full Text] [Related]
2. Cell-Derived Microparticles in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis. Li S; Wei J; Zhang C; Li X; Meng W; Mo X; Zhang Q; Liu Q; Ren K; Du R; Tian H; Li J Cell Physiol Biochem; 2016; 39(6):2439-2450. PubMed ID: 27832642 [TBL] [Abstract][Full Text] [Related]
4. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance. Giannella A; Radu CM; Franco L; Campello E; Simioni P; Avogaro A; de Kreutzenberg SV; Ceolotto G Cardiovasc Diabetol; 2017 Sep; 16(1):118. PubMed ID: 28927403 [TBL] [Abstract][Full Text] [Related]
5. Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus. Spectre G; Mobarrez F; Stålesen R; Östenson CG; Varon D; Wallen H; Hjemdahl P Platelets; 2019; 30(3):348-355. PubMed ID: 29547014 [TBL] [Abstract][Full Text] [Related]
6. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis. Berezin AE; Kremzer AA; Berezina TA; Martovitskaya YV Acta Clin Belg; 2016 Feb; 71(1):38-45. PubMed ID: 27075791 [TBL] [Abstract][Full Text] [Related]
7. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis. Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306 [TBL] [Abstract][Full Text] [Related]
8. Increased circulating microparticles in women with preeclampsia. Zhang Y; Zhao C; Wei Y; Yang S; Cui C; Yang J; Zhang J; Qiao R Int J Lab Hematol; 2018 Jun; 40(3):352-358. PubMed ID: 29520961 [TBL] [Abstract][Full Text] [Related]
9. Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction. Hosseinzadeh S; Noroozian M; Mortaz E; Mousavizadeh K Metab Brain Dis; 2018 Feb; 33(1):293-299. PubMed ID: 29209923 [TBL] [Abstract][Full Text] [Related]
10. Microparticles are related to cognitive and functional status from normal aging to dementia. A Magalhães C; M Campos F; M G Loures C; G Fraga V; de Souza LC; C Guimarães H; T G Cintra M; A Bicalho M; G Carvalho M; P Sousa L; Caramelli P; B Gomes K J Neuroimmunol; 2019 Nov; 336():577027. PubMed ID: 31472398 [TBL] [Abstract][Full Text] [Related]
11. Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and Circulating Microparticles in Type 1 Diabetes Mellitus. Zahran AM; Mohamed IL; El Asheer OM; Tamer DM; Abo-ELela MGM; Abdel-Rahim MH; El-Badawy OHB; Elsayh KI Clin Appl Thromb Hemost; 2019; 25():1076029618825311. PubMed ID: 30760002 [TBL] [Abstract][Full Text] [Related]
13. Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C. Zuwala-Jagiello J; Pazgan-Simon M; Murawska-Cialowicz E; Simon K In Vivo; 2017; 31(5):1027-1034. PubMed ID: 28882977 [TBL] [Abstract][Full Text] [Related]
14. Microparticles as new markers of cardiovascular risk in diabetes and beyond. Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919 [TBL] [Abstract][Full Text] [Related]
15. Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease. Almquist T; Mobarrez F; Jacobson SH; Wallén H; Hjemdahl P Nephrol Dial Transplant; 2016 Jun; 31(6):944-52. PubMed ID: 26394646 [TBL] [Abstract][Full Text] [Related]
17. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease. Zhang H; Hu W; Zhang G Int Urol Nephrol; 2020 Aug; 52(8):1517-1522. PubMed ID: 32458209 [TBL] [Abstract][Full Text] [Related]
18. Phosphatidylserine on microparticles and associated cells contributes to the hypercoagulable state in diabetic kidney disease. Yu M; Xie R; Zhang Y; Liang H; Hou L; Yu C; Zhang J; Dong Z; Tian Y; Bi Y; Kou J; Novakovic VA; Shi J Nephrol Dial Transplant; 2018 Dec; 33(12):2115-2127. PubMed ID: 29529237 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Jansen F; Wang H; Przybilla D; Franklin BS; Dolf A; Pfeifer P; Schmitz T; Flender A; Endl E; Nickenig G; Werner N Cardiovasc Diabetol; 2016 Mar; 15():49. PubMed ID: 27005938 [TBL] [Abstract][Full Text] [Related]
20. Formation of microparticles in the injured brain of patients with severe isolated traumatic brain injury. Nekludov M; Mobarrez F; Gryth D; Bellander BM; Wallen H J Neurotrauma; 2014 Dec; 31(23):1927-33. PubMed ID: 24956150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]